Possible Hemolytic Uremic Syndrome in three cats after renal transplantation and cyclosporine therapy

Veterinary Surgery

Volumn 28, Issue 3, 1999, Pages 135-140

  Aronson, Lillian R ^a   Gregory, Clare ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; CAT; CAT DISEASE; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; FEMALE; GRAFT REJECTION; HEMOLYTIC UREMIC SYNDROME; KIDNEY TRANSPLANTATION; MALE; PATHOPHYSIOLOGY;

ANIMALS; CAT DISEASES; CATS; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HEMOLYTIC-UREMIC SYNDROME; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE;

EID: 0033125308     PISSN: 01613499     EISSN: None     Source Type: Journal    
DOI: 10.1053/jvet.1999.0135     Document Type: Article

References (29)

1. Katznelson S, Wilkinson A, Rosenthal TR, et al: Cyclosporine-induced hemolytic uremic syndrome: Factors that obscure its diagnosis. Transplant Proc 26:2608-2609, 1994
2. Galli FC, Damon LE, Tomlanovich SJ, et al: Cyclosporine-induced hemolytic uremic syndrome in a heart transplant recipient. J Heart LungTransplant 12:440-444, 1993
3. Gharpure VS, Devine SM, Holland HK, et al: Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation. Bone Marrow Transplant 16:715-716, 1995
4. Young BA, Marsh CL, Alpers CE, et al: Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation. Amer J Kid Dis 28:561-571, 1996
5. Agarwal A, Mauer SM, Matas AJ, et al: Recurrent hemolytic uremic syndrome in an adult renal allograft recipient: Current concepts and management. J Am Soc Nephrol 6:1160-1169, 1995
6. Lucca LJ, Ressurreicao FAMS, Ferraz RS, et al: De novo hemolytic uremia syndrome: A rare adverse effect in renal transplant recipients immunosuppressed with cyclosporine. Transplant Proc 24:3098-3099, 1992
7. Scantleberry VP, Shapiro R, McCauley J, et al: Renal transplantation under cyclosporine and FK506 for hemolytic uremic syndrome. Transplant Proc 27:842-843, 1995
8. Conlon PJ, Brennana DC, Pfaf WW, et al: Renal transplantation in adults with thrombotic thrombocytopenic purpura/ haemolytic-uraemic syndrome. Nephrol Dial Transplant 11:1810-1814, 1996
9. McCauley J, Shapiro R, Bronster O, et al: Renal transplantation under FK506 in patients with previous loss of renal function due to hemolytic uremic syndrome. Transplant Proc 23:3068-3070, 1991
10. Azuma E, Hirayama M, Nakano T, et al: Acute hemolysis during cyclosporine therapy successfully treated with vitamin E. Bone Marrow Transplant 16:321-322, 1995
11. George JN, El-Harake M: Thrombocytopenia due to enhanced platelet destruction by nonimmunologic mechanisms. Hemostas Throm 128:1290-1313, 1993
12. Gordjani N, Sutor AH, Lothar ZB, et al: Hemolytic uremic syndrome in childhood. Semin Throm Hemostas 23:281-293, 1997
13. Curtis JJ: Nature of renal injury associated with cyclosporine. Transplant Proc 28:2094-2096,1996
14. van de Kar N, Sauerwein RW, Demacker PNM, et al: Plasma cytokine levels in hemolytic uremic syndrome. Nephron 71:309-313, 1995
15. Neild GH, Rocchi G, Imberti L, et al: Effect of cyclosporine on prostacyclin synthesis by vascular tissue in rabbits. Transplant Proc 15:2398-2400, 1983
16. Buturovic J, Kandus A, Malovrh M, et al: Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: Resolution without specific therapy. Transplant Proc 22:1726-1727, 1990
17. Leithner C, Sinzinger H, Pohanka E, et al: Occurrence of hemolytic uremic syndrome under cyclosporine treatment: Accident or possible side effect mediated by a lack of prostacyclin-stimulating plasma factor. Transplant Proc 15: 2787-2789, 1983
18. Candinas D, Keusch G, Schlumpf R, et al: Prognostic factors of hemolytic uremic syndrome in renal allografts. Transplant Proc 25:1041-1042, 1993
19. Neild GH, Rocchi G, Imberti L, et al: Effect of cyclosporine A on prostacyclin synthesis by vascular tissue. Thrombosis Res 32:373-379, 1983
20. Moake JL, Rudy CK, Troll JH, et al: Unusually larger plasma factor VIII: von Willebrand factor multimers in chronic relapsing trombotic thrombocytopenic purpura. Thrombosis Res 23:1432-1435, 1982
21. Herlitz H, Peterson A, Sigstrom L, et al: The arginine-nitric oxide pathway in thrombotic microangiopathy. Scand J Urol Nephrol 31:477-479, 1997
22. Noris M, Chempharm D, Ruggenenti P, et al: Increased nitric oxide formation in recurrent thrombotic microangiopathy: A possible mediator of microvascular injury. Am J Kid Dis 27:790-796, 1996
23. Coffman TM, Carr DR, Yarger WE, et al: Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity. Transplantation 43: 282-285, 1987
24. Remuzzi G, Zoja C, Rossi EC: Prostacyclin in thrombotic microangiopathy. Semin Hematol 24:110-113, 1987
25. Dyck RF, Kappell JE, Sheridan D, et al: Reversible cyclosporine-associated hemolytic uremic syndrome in a renal transplant recipient: A role for PAF. Transplant Proc 18: 228-229, 1986
26. van Gelder T, Klaassen RJL, van Riemsdijk-van Overbeeke, et al: Mycophenolate mofetil and prednisone as maintenance treatment after kidney transplantation. Transplant 63:1530-1531, 1997
27. Venkat KK, Tkach D, Kupin W, et al: Reversal of cyclosporine-associated hemolytic-uremic syndrome by plasma exchange with fresh-frozen plasma replacement in renal transplant recipients. Transplant proc 23:1256-1257, 1991
28. Grino JM, Caralps A, Carreras L, et al: Apparent recurrence of hemolytic uremic syndrome in azathioprine-treated allograft recipients. Nephron 49:301-304, 1988
29. Randhawa PS, Tsamandas AC, Magnone M, et al: Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy. Am J Surg Path 20:306-312, 1996